VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
methylene blue dye
Preclinical
Small molecule
U
University of Sao Paulo
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Periodontal Disease
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Periodontal Disease
Preclinical
Completed
Clinical
Trials by Indication
[1]
Periodontal Disease
1 trial
Antimicrobial Photodynamic Therapy as an Adjunct Treatment for Periodontal Disease in Down's Syndrome Patients
Completed
·
U
University of Sao Paulo
·
N/A
·
NCT02938988
·
33 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for methylene blue dye. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
methylene blue dye compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for methylene blue dye. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
University of Sao Paulo company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
U
University of Sao Paulo
Related News